These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 25107915)
1. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis. Jung HY; Fattet L; Yang J Clin Cancer Res; 2015 Mar; 21(5):962-968. PubMed ID: 25107915 [TBL] [Abstract][Full Text] [Related]
2. Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics. Zhang J; Hu Z; Horta CA; Yang J Semin Cancer Biol; 2023 Jan; 88():46-66. PubMed ID: 36521737 [TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition and inflammation at the site of the primary tumor. Dominguez C; David JM; Palena C Semin Cancer Biol; 2017 Dec; 47():177-184. PubMed ID: 28823497 [TBL] [Abstract][Full Text] [Related]
4. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Du B; Shim JS Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225 [TBL] [Abstract][Full Text] [Related]
5. Tumor and its microenvironment: a synergistic interplay. Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661 [TBL] [Abstract][Full Text] [Related]
6. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis. Li H; Xu F; Li S; Zhong A; Meng X; Lai M Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180 [TBL] [Abstract][Full Text] [Related]
7. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis. Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983 [TBL] [Abstract][Full Text] [Related]
8. Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy. Chen J; Ding ZY; Li S; Liu S; Xiao C; Li Z; Zhang BX; Chen XP; Yang X Theranostics; 2021; 11(3):1345-1363. PubMed ID: 33391538 [TBL] [Abstract][Full Text] [Related]
9. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Schliekelman MJ; Gibbons DL; Faca VM; Creighton CJ; Rizvi ZH; Zhang Q; Wong CH; Wang H; Ungewiss C; Ahn YH; Shin DH; Kurie JM; Hanash SM Cancer Res; 2011 Dec; 71(24):7670-82. PubMed ID: 21987723 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation. Markopoulos GS; Roupakia E; Marcu KB; Kolettas E Cells; 2019 Sep; 8(10):. PubMed ID: 31557902 [TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis. Drak Alsibai K; Meseure D Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced epithelial to mesenchymal transition in cancer. Hapke RY; Haake SM Cancer Lett; 2020 Sep; 487():10-20. PubMed ID: 32470488 [TBL] [Abstract][Full Text] [Related]
13. Autocrine Fibronectin Inhibits Breast Cancer Metastasis. Shinde A; Libring S; Alpsoy A; Abdullah A; Schaber JA; Solorio L; Wendt MK Mol Cancer Res; 2018 Oct; 16(10):1579-1589. PubMed ID: 29934326 [TBL] [Abstract][Full Text] [Related]
14. TGFβ and matrix-regulated epithelial to mesenchymal transition. Moustakas A; Heldin P Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266 [TBL] [Abstract][Full Text] [Related]
15. Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition. Balaji S; Kim U; Muthukkaruppan V; Vanniarajan A Life Sci; 2021 Sep; 280():119750. PubMed ID: 34171378 [TBL] [Abstract][Full Text] [Related]
16. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Chen HT; Liu H; Mao MJ; Tan Y; Mo XQ; Meng XJ; Cao MT; Zhong CY; Liu Y; Shan H; Jiang GM Mol Cancer; 2019 May; 18(1):101. PubMed ID: 31126310 [TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Erin N; Grahovac J; Brozovic A; Efferth T Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188 [TBL] [Abstract][Full Text] [Related]
18. Targeting EMT in Cancer with Repurposed Metabolic Inhibitors. Ramesh V; Brabletz T; Ceppi P Trends Cancer; 2020 Nov; 6(11):942-950. PubMed ID: 32680650 [TBL] [Abstract][Full Text] [Related]
19. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Yang JD; Nakamura I; Roberts LR Semin Cancer Biol; 2011 Feb; 21(1):35-43. PubMed ID: 20946957 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of tumour microenvironment in the progression and development of oral cancer. Mughees M; Sengupta A; Khowal S; Wajid S Mol Biol Rep; 2021 Feb; 48(2):1773-1786. PubMed ID: 33492572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]